Searchable abstracts of presentations at key conferences in endocrinology

ea0031p64 | Clinical practice/governance and case reports | SFEBES2013

Conn's syndrome with normal plasma renin aldosterone ratio

Thida Myat , Andrews Julie , Barth Julian , Orme Steve

Background: Conn’s syndrome accounts for 35% of primary hyperaldosteronism. Elevated plasma aldosterone concentration to renin activity is widely used as a screening diagnostic tool. However, we report an unusual presentation of Conn’s syndrome with normal plasma renin aldosterone ratio.A 48-year-old man was seen in endocrine clinic with uncontrolled hypertension and severe hypokalemia. Primary hyperaldosteronism was suspected with blood pressu...

ea0019p76 | Clinical practice/governance and case reports | SFEBES2009

The ‘new start’ weight loss programme: developing and piloting a real world intervention for patients with severe morbid obesity

Douek IF , Andrews RC , Watson S , Grant T , Edmond JR

Background: In a research setting, complex behavioural interventions are effective in changing lifestyle behaviour and inducing weight loss. However, these are viewed as requiring a high number of different health care professionals to be successful and thus few are available in the NHS setting. Here we describe how we developed and piloted a complex behavioural intervention for participants with severe morbid obesity.Methods: Using input from a psycholo...

ea0095p44 | Gonadal, DSD and Reproduction 1 | BSPED2023

Novel association of NUP107 variants in XY DSD

Edavana Shaju , Yadav Viba , Bajpai Anurag , Andrews Afia

XY disorders of sexual development (DSD) are rare causes of primary amenorrhea and are associated with significant diagnostic and therapeutic implications. We report a novel association of compound heterozygous missense NUP107 variants in a girl with hypergonadotropic hypogonadism and XY karyotype. This 17-year-old girl born of consanguineous marriage presented with absent breast development and primary amenorrhea. Her past medical history included the surgical removal of an a...

ea0078OC5.1 | Oral Communications 5 | BSPED2021

Evaluating UK Referral Criteria for Children with Short Stature in a Tertiary Paediatric Endocrinology Centre

White Gemma , Cosier Shakira , Andrews Afiya , Willemsen Ruben H. , Savage Martin O. , Storr Helen L.

Background: Childhood growth monitoring aims to identify growth failure and detect underlying pathology. According to UK guidance, height <-2.7 standard deviation score (SDS) (<0.4th percentile) is used as the referral threshold. Additional referral criteria include height deficit (HSDS-target height SDS) <-2.0 and height velocity (HV) SDS <-1.3. Lack of routine HV and mid-parental height calculation, combined with stricter cut-offs compared to other European c...

ea0078OC6.5 | Oral Communications 6 | BSPED2021

Highlighting POLE1 mutations as a cause of adrenal insufficiency

Dhamodaran Madhuvanthi , Dyke Mark , Walston Florence , Booth David , Andrews Katrina , Armstrong Ruth , Webb Emma

Background: Compound heterozygous POLE1 mutations have previously been described as a cause of IMAGe syndrome. The severity of the adrenal insufficiency (AI) at initial presentation has been a subject of ongoing debate. Case report: At 22 weeks gestation the proband’s mother was referred to paediatric endocrinology for low oestriol on antenatal quadruple testing. The pregnancy was complicated by severe growth restriction leading to emergency caesare...

ea0051p010 | Adrenal | BSPED2017

An unusual presentation of congenital lipoid adrenal hyperplasia and novel STAR mutation in two siblings

Andrews Edward , Taylor Carl , Metherell Lou , Buonocore Frederica , Achermann John , Maharaj Avinaash , Davies Justin H

Introduction: Congenital lipoid adrenal hyperplasia (CLAH) is rare and caused by mutations in the steroidogenic acute regulatory (STAR) gene, which is involved in a key step in the synthesis of pregnenolone from cholesterol. Cases typically present in the first days of life with severe adrenal crisis, salt wasting and severely disrupted androgen secretion which may result in sex reversal in 46, XY individuals.Case report: We present a 21-month-o...

ea0051p056 | Pituitary and growth | BSPED2017

Embedding electronic growth charts into clinical practice at a children’s hospital

Andrews Edward , Wootton Stephen , Cable David , Marchant Alastair , Miller Harriet , Davies Justin

Background: Accurate evaluation of growth is a key assessment of child health, in the UK use of a paper growth chart is currently standard practice. Our trust had a drive to become paper light thus there needed to be a way to store growth data electronically. Growth data is often incompletely documented. A previous review of children’s outpatient attendances at our hospital found that across medical, surgical and tertiary specialties only 33% of children had growth data d...

ea0065cmw2.2 | Hyperparathyroidism | SFEBES2019

Genetic testing in hyperparathyroidism – who to test and why

Mariathasan Sashi , Andrews Katrina , Thompson Edward , Armstrong Ruth , Simpson Helen , Casey Ruth , Park Soo-Mi

Primary hyperparathyroidism (PHPT) is a common endocrine disorder with a prevalence of 0.86% in Europe. Approximately 10% of cases are hereditary. Syndromic PHPT occurs as part of multiple endocrine neoplasia (MEN)1, MEN4, MEN2A and hyperparathyroidism jaw tumour syndrome. Non-syndromic causes include familial hypocalciuric hypercalcaemia. Establishing the underlying genetic cause allows for targeted, cost effective management. Current guidelines recommend that genetic testing...

ea0063oc1.1 | Calcium and Bone | ECE2019

Genetic testing for hereditary hyperparathyroidism in a large UK cohort

Mariathasan Sashi , Andrews Katrina , Thompson Edward , Armstrong Ruth , Park Soo-Mi , Casey Ruth

Primary hyperparathyroidism (PHPTH) is a common endocrine disorder and it is estimated that 10% of cases are hereditary, related to syndromes including; multiple endocrine neoplasia (MEN) type 1, MEN type 4, MEN2A and hereditary hyperparathyroidism jaw tumour syndrome. Further hereditary cases can occur in the absence of syndromic features such as familial hypercalcemia hypocalcuria. Identifying cases of hereditary PHPTH enables a personalised medicine approach. Current guidel...

ea0059p160 | Obesity &amp; metabolism | SFEBES2018

Screening for Cushing’s syndrome in a tier 3 weight management service

Glyn Tessa , Ho May , Lambert Anthony Paul , Thomas Julia , King Rhodri , Douek Isabelle , Andrews Robert

There is limited evidence for the role of screening for Cushing’s syndrome (CS). Patients referred to the specialist medical weight management service at Musgrove Park Hospital have routinely been screened for CS with either an overnight dexamethasone suppression test (ODST) or two 24hour urinary free cortisol (UFC) if evidence of dysglycaemia. We retrospectively analysed the results of all patients referred to the service between 2013–2016. 794 patients were seen as...